Swiss Longevity Week
From 21-26 November 2021, several Deep Knowledge Group' Partners and Senior Executives visited Switzerland (Geneva, Zurich and Basel) to host a number of invitation-only Longevity Finance and Investment events, and to engage key Swiss stakeholders (investors, financial executives and government officials) on the prospects for transforming Switzerland into the world’s leading full-scope Longevity Finance, Industry, Biomedicine and Policy Hub (Swiss Longevity Valley).
The Longevity Event in Geneva
On 23 November 2021 Deep Knowledge Group hosted an invitation-only Longevity Event in Geneva: ‘INVESTING IN LONGEVITY’
The event covered several important topics, including:
Investing into the Largest Wealth Creation Opportunity of The Decade
Private Equity, Venture Capital, Public Markets
De-Risking and Optimization of Investments
Practical Human Longevity
Hype vs Reality
Deep Knowledge Group General Partner Dmitry Kaminskiy delivered presentation entitled Longevity Industry Overview 2021-2022, alongside a presentation on Private Equity & Venture, Longevity Assets and Financial Products by Deep Knowledge Group Managing Partner Stefan Hascoet, who also leads the Group’s Swiss-based financial branch, Deep Knowledge Ventures Swiss, located in Geneva.
During the event, we witnessed strong interest in the Longevity Industry from a number of investors, financial executives and industry professionals in attendance, with whom we spoke about the future perspectives of the industry.
Dmitry Kaminskiy also delivered a presentation of his series of published and upcoming Longevity Books, including Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History, Longevity Financial Industry: Health as the New Wealth, Longevity FinTech, WealthTech, InvestTech, InsurTech, AgeTech, and the Coming Rise of Longevity Banks, Investment Banks, Stock Exchanges, ETFs, Indices, and Novel Financial Instruments and Derivatives, and Longevity Industry 2.0: DeepTech Engineering the Accelerated Trajectory of Human Longevity: The Blueprint and Pathway from Longevity Industry 1.0 to 2.0, but with major emphasis on his newest book, Biomarkers of Human Longevity: ’Data Science for Accelerating Aging Research and R&D and The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision Making and De-Risking’, to the audience.
The Longevity Event in Zurich
The following day, on 24 November 2021, a parallel ‘INVESTING IN LONGEVITY’ private event was hosted by Deep Knowledge Group in Zurich, Switzerland.
Deep Knowledge Group General Partner Dmitry Kaminskiy delivered a presentation on Longevity Investment De-Risking Methods and Diversification Strategies, alongside a talk by Remus Stanescu, Director of Structured Products at Deep Knowledge Group’s UK-based financial branch, Longevity Financial Advisors, located in London.
The event also featured early discussions on Deep Knowledge Group’s biomarkers subsidiary, Quant Biomarkers company (a data-driven biotechnology, precision medicine and financial services company focused on applications of Longevity Biomarkers across numerous sectors, including InsurTech and InvestTech).
'‘Longevity Meets Basel' Conference
On 25 November 2021, in Basel, Switzerland, several Deep Knowledge Group Partners and senior executives were in attendance for the ’Longevity Meets Basel', a conference by the prestigious Weizman Institute of Science (WYEN), hosted by Wyen Board Member Dr. Sanja Baumann-Tomovska.
During the conference, Deep Knowledge Group General Partner Dmitry Kaminskiy delivered a keynote presentation entitled ‘Biomarkers of Human Longevity as the Critical Catalyst for Tangible Investment Decision-Making and De-Risking’.
Dmitry Kaminskiy also сhaired a Panel Discussion (Aging: The Longevity Dividend), featuring a number of Longevity investment, policy and biomedicine firms including Joanna Bensz (Co-Founder and CEO, Longevity Center; CEO, International Institute of Longevity), Leo Grunstein (Founder and CEO of Spiden AG, Chairman of Venture Builder LG Capital AG), Dr. Yaron Daniely (Partner, Amoon), Dr. Tobias Reichmuth (Founding Partner, Maximon), Garri Zmudze (Founding Partner, Longe-VC), and Dr. Matthias Steger (Co-Founder and CEO, Rejuveron Life Sciences).
Dmitry Kaminskiy as a Speaker at the WYEN Conference 'Longevity Meets Basel'
Dmitry Kaminskiy delivers his presentation at ‘Longevity Meets Basel’ Conference
Dmitry Kaminskiy and Prince Michael of Liechtenstein and Founder of the International Institute of Longevity Joanna Bensz
Dr. Sanja Baumann-Tomovska and Dmitry Kaminskiy as Moderators of the Panel Discussion (Aging: The Longevity Dividend)
Swiss Analytical Materials
Notable Acknowledgements from Switzerland
Former President of Switzerland
Alain Berset is Federal Councillor, Head of the Federal Department of Home Affairs (DFI) and former President of the Swiss Confederation. Alain Berset mentioned Deep Knowledge Group's COVID-19 Safety Ranking published on 4th of June 2020 on his Twitter account
Swiss Embassy in France tweeted about Deep Knowledge Group's COVID-19 Safety Ranking published on 4th of June 2020.
Professor Didier Pittet
Director of the Infection Control Programme
The infectious diseases expert and the director of the Infection Control Programme and WHO Collaborating Centre on Patient Safety, University Hospital of Geneva, Switzerland. Since 2005, Pittet is also the External Lead of the World Health Organization (WHO) Global Patient Safety Challenge "Clean Care is Safer Care" and African Partnerships for Patient Safety
Federal Department of Foreign Affairs
House of Switzerland is managed by Presence Switzerland, the unit of the Federal Department of Foreign Affairs that is competent for the image of Switzerland abroad, and implements the strategy of the Federal Council on Switzerland’s communication abroad. House of Switzerland tweeted about Deep Knowledge Group's COVID-19 Safety Ranking published on 4th of June 2020.